UNIVERCELL BIOSOLUTIONS
Univercell-Biosolutions has coupled the potential of human hiPS and hES cells with cellular reprogramming and directed differentiation technologies. Together these innovations yield purified populations of specific human cell types for drug-discovery applications. Univercell-Biosolutions has developed Mesopure® to provide a pure (>99%) population of cardiovascular progenitors. Univercell-Biosolutions works with clinicians, academics and industry leaders to develop next-generation homogeneous, mature, functional and differentiated human cells with physiological characteristics closely matching those of adult differentiated cells in vivo. Univercell-Biosolutions’ goals are to accelerate the discovery of new therapeutics and to reduce the drug failure rate in clinical trials.
UNIVERCELL BIOSOLUTIONS
Social Links:
Industry:
Biotechnology Health Care Wellness
Founded:
2010-01-01
Address:
Toulouse, Midi-Pyrenees, France
Country:
France
Website Url:
http://www.univercell-biosolutions.com
Total Employee:
11+
Status:
Active
Contact:
+33 9 72 42 11 62
Email Addresses:
[email protected]
Total Funding:
50 K EUR
Technology used in webpage:
Domain Not Resolving Contact Form 7
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
MaxWell Biosystems
MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.
Nutricion3g
Nutricion3g offers accurate nutritional recommendations based on the genetic pattern of each individual.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Univercell Biosolutions
Official Site Inspections
http://www.univercell-biosolutions.com
- Host name: lb-212-210.above.com
- IP address: 103.224.212.210
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
